R01 CA121781/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2004	1
2005	1
2007	1
2008	4
2009	2
2010	8
2011	2
2012	1
2013	3
2014	2
2015	1
2024	0

1

Renal cell carcinoma: where will the state-of-the-art lead us?

Brannon AR, Rathmell WK. Brannon AR, et al. Curr Oncol Rep. 2010 May;12(3):193-201. doi: 10.1007/s11912-010-0093-4. Curr Oncol Rep. 2010. PMID: 20425079 Free PMC article. Review.

2

Recent updates in renal cell carcinoma.

Rathmell WK, Godley PA. Rathmell WK, et al. Curr Opin Oncol. 2010 May;22(3):250-6. doi: 10.1097/CCO.0b013e328337a5d2. Curr Opin Oncol. 2010. PMID: 20154618 Free PMC article. Review.

3

VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis and treatment.

Rathmell WK, Chen S. Rathmell WK, et al. Expert Rev Anticancer Ther. 2008 Jan;8(1):63-73. doi: 10.1586/14737140.8.1.63. Expert Rev Anticancer Ther. 2008. PMID: 18095884 Free PMC article. Review.

4

VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacy.

Cowey CL, Rathmell WK. Cowey CL, et al. Curr Oncol Rep. 2009 Mar;11(2):94-101. doi: 10.1007/s11912-009-0015-5. Curr Oncol Rep. 2009. PMID: 19216840 Free PMC article. Review.

5

VHL: oxygen sensing and vasculogenesis.

Rathmell WK, Simon MC. Rathmell WK, et al. J Thromb Haemost. 2005 Dec;3(12):2627-32. doi: 10.1111/j.1538-7836.2005.01441.x. Epub 2005 Jun 24. J Thromb Haemost. 2005. PMID: 15975138 Free article. Review. No abstract available.

6

Emerging molecular classification in renal cell carcinoma: implications for drug development.

Hacker KE, Rathmell WK. Hacker KE, et al. Target Oncol. 2010 Jun;5(2):75-84. doi: 10.1007/s11523-010-0144-7. Epub 2010 Jul 20. Target Oncol. 2010. PMID: 20645016 Free PMC article. Review.

7

Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma.

Liu H, Brannon AR, Reddy AR, Alexe G, Seiler MW, Arreola A, Oza JH, Yao M, Juan D, Liou LS, Ganesan S, Levine AJ, Rathmell WK, Bhanot GV. Liu H, et al. BMC Syst Biol. 2010 Apr 27;4:51. doi: 10.1186/1752-0509-4-51. BMC Syst Biol. 2010. PMID: 20420713 Free PMC article.

8

HIF1α and HIF2α exert distinct nutrient preferences in renal cells.

Arreola A, Cowey CL, Coloff JL, Rathmell JC, Rathmell WK. Arreola A, et al. PLoS One. 2014 May 30;9(5):e98705. doi: 10.1371/journal.pone.0098705. eCollection 2014. PLoS One. 2014. PMID: 24879016 Free PMC article.

9

VHL and PTEN loss coordinate to promote mouse liver vascular lesions.

Chen S, Sanford CA, Sun J, Choi V, Van Dyke T, Samulski RJ, Rathmell WK. Chen S, et al. Angiogenesis. 2010 Mar;13(1):59-69. doi: 10.1007/s10456-010-9164-2. Epub 2010 Mar 11. Angiogenesis. 2010. PMID: 20221685 Free PMC article.

10

Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma.

Teng BL, Hacker KE, Chen S, Means AR, Rathmell WK. Teng BL, et al. Mol Oncol. 2011 Oct;5(5):465-74. doi: 10.1016/j.molonc.2011.06.002. Epub 2011 Jun 28. Mol Oncol. 2011. PMID: 21764651 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year